Sheridan Healthcare Inc., a company backed by Hellman & Friedman, has named John Carlyle as its chief executive. Carlyle previously served as founder and CEO of Accuro Healthcare Solutions; founder and CEO of Magella Healthcare; co-founder and CEO of Concentra; and Chief Financial Officer of Medical Care International. Sheridan is a provider of hospital-based physician services including anesthesia, radiology, emergency medicine, and neonatology.
Sheridan Healthcare, Inc., a portfolio company of private equity firm Hellman & Friedman LLC, today announced that John Carlyle has joined the company as Chief Executive Officer. Mr. Carlyle is a seasoned healthcare executive with more than 25 years of senior leadership success in the industry. He has previously served as founder and CEO of Accuro Healthcare Solutions, founder and CEO of Magella Healthcare, co-founder and CEO of Concentra, and Chief Financial Officer of Medical Care International.
Mitchell Eisenberg, MD, Sheridan co-founder and current CEO, will assume the role of Executive Chairman of the Board. Co-founder Lewis Gold, MD, will continue in his current role as Executive Vice Chairman of the Board.
Mr. Carlyle said, “I am very excited to join Sheridan Healthcare and am committed to building upon the work of the company’s founders to expand Sheridan’s reach while continuing to deliver outstanding results to patients, hospitals and physicians. Working with Sheridan’s President, Robert Coward, and the other management team members in partnership with Hellman & Friedman, I’m confident we will continue to thrive.”
“John’s breadth of experience managing successful healthcare services companies will ensure Sheridan both continues its industry leadership in physician services and capitalizes on new opportunities in today’s dynamic healthcare environment,” said Eisenberg.
In announcing this appointment, Hellman & Friedman Managing Director Allen Thorpe added, “We are delighted to welcome John to Sheridan. His background leading successful, large-scale healthcare services businesses and his deep understanding of the dynamic physician and hospital sectors make him the ideal person to drive Sheridan’s next phase of growth.”
Mr. Carlyle has served on numerous other boards of directors, including, Eagle Hospital Physicians, Odyssey Healthcare, Concentra, and Pediatrix Medical Group (now known as Mednax). He currently serves on the board of directors of Vision Source and Healthcare Solutions.
About Sheridan Healthcare, Inc.
Sheridan Healthcare, Inc. (www.shcr.com) is a national provider of hospital-based physician services including anesthesia, radiology, emergency medicine, neonatology and other pediatric subspecialties. Sheridan, its subsidiaries and affiliates currently operate in 23 states and employ more than 2,200 healthcare providers. Sheridan’s anesthesia division, established in 1953, is the leading anesthesia services provider in the country. In addition to physician and allied health services, Sheridan also provides comprehensive support, training and management in non-clinical areas. Sheridan is recognized by the National Committee for Quality Assurance as a certified physician organization.
About Hellman & Friedman LLC
Hellman & Friedman LLC is a leading private equity investment firm with offices in San Francisco, New York and London. Since its founding in 1984, Hellman & Friedman has raised and, through its affiliated funds, managed over $25 billion of committed capital. The Firm focuses on investing in superior business franchises and serving as a value-added partner to management in select industries including healthcare, internet & digital media, software, business & marketing services, financial services, insurance, media and energy & industrials.
Take your pick!
- Buyouts delivers exclusive news and analysis about private equity deals, fundraising, top-quartile managers and more. Get your FREE trial or subscribe now.
- VC Journal provides exclusive news and analysis about venture capital deals, fundraising, top-quartile investors and more. Get your FREE trial or subscribe now.